Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nasal Carbon Dioxide for Trigeminal Neuralgia
NCT02473016Phase 2Completed
- Sponsor
- Capnia, Inc.
- Start
- Sep 2015
- Primary completion
- Mar 2017
- Modality
- Inhalation Devices
- Countries
- 1
01
Overview
A Phase 2 trial of Carbon dioxide in trigeminal neuralgia (TN), sponsored by Capnia, Inc.. Started Sep 2015; status: completed.
02
Drugs
Carbon dioxide
03
Conditions
trigeminal neuralgia (TN)
Beyond the preview
Go deeper on NCT02473016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02473016.